Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana

British Journal of Dermatology

Volumn 151, Issue 6, 2004, Pages 1165-1171

  Couppié, Pierre ^a,b   Clyti, E ^a   Sobesky, M ^a,b   Bissuel, F ^c   Del Giudice, P ^a   Sainte Marie, D ^a   Dedet, J P ^d   Carme, B ^a,b   Pradinaud, R ^a,b  

^a CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^b UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^c Centre hospitalier de St Laurent du Maroni   (French Guiana)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Cutaneous leishmaniasis; French Guiana; Human immunodeficiency virus; Leishmania guyanensis

Indexed keywords

CD4 ANTIGEN; MEGLUMINE ANTIMONATE; PENTAMIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FRENCH GUIANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LEISHMANIA; LYMPHADENOPATHY; LYMPHANGITIS; LYMPHOCYTE COUNT; MALE; PARASITE ISOLATION; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; SKIN LEISHMANIASIS; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PENTAMIDINE; RECURRENCE; TREATMENT OUTCOME;

EID: 11144332430     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06226.x     Document Type: Article

References (33)

1. Alvar J, Cañavate C, Gutierrez-Solar B et al. Leishmania and human immunodeficiency virus co-infection: the first 10 years. Clin Microbiol Rev 1997; 10: 298-319.
2. Del Giudice P, Mary-Krause M, Pradier C et al. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis 2002; 186: 1366-70.
3. Mattos M, Caiza A, Fernandes O et al. American cutaneous leishmaniasis associated to HIV infection; report of 4 cases. J Eur Acad Dermatol Venereol 1998; 10: 218-25.
4. Barro-Traore F, Ye-Ouattara D, Traore A et al. Leishmaniose cutanée pseudo-lépromateuse: analyse de six cas à Ouagadougou (Burkina Faso). Nouv Dermatol 2002; 21: 156-61.
5. Sobesky M, Dabis F, Le Beux P. HIV/AIDS epidemic in French Guiana: 1979-97. J Acquir Immun Defic Syndr 2000; 24: 178-81.
6. Dedet JP, Pradinaud R, Gay F. Epidemiological aspects of human cutaneous leishmaniasis in French Guiana. Trans R Soc Trop Med Hyg 1989; 83: 616-20.
7. Carme B, Aznar C, Pradinaud R. Absence of a proven resurgence of Chagas disease or cutaneous leishmaniasis in French Guiana over the last two decades. Ann Trop Med Parasitol 2001; 95: 623-5.
8. Desjeux P, Dedet JP. Isoenzyme characterisation of 112 Leishmania isolates from French Guiana. Trans R Soc Trop Med Hyg 1989; 83: 610-12.
9. Raccurt C, Pradinaud R, Couppié P et al. Leishmania (Viannia) braziliensis Vianna, 1911 en Guyane Française. Aspects cliniques, thérapeutiques et épidémiologiques chez le 9ème cas humain diagnostiqué, Bull Soc Pathol Exot 1996; 89: 341-4.
10. Sainte-Marie D, Pradinaud R, Cassiede P. Manifestations dermatologiques et vénérélogiques observées dans le SIDA en Guyane Française. Nouv Dermatol 1988; 7: 419-23.
11. Nacher M, Carme B, Saint Marie D et al. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol 2002; 96: 773-80.
12. Coura JR, Galvao-Castro B, Grimaldi G. Disseminated American cutaneous leishmaniasis in a patient with AIDS. Mem Inst Oswaldo Cruz 1987; 82: 581-2.
13. Machado ES, Braga MDP, Da-Cruz AM et al. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis in a patient with AIDS: a case report. Mem Inst Oswaldo Cruz 1992; 87: 487-92.
14. Echevarria J, Campos P, Chang J et al. Mucocutaneous leishmaniasis and AIDS: case report. Trans R Soc Trop Med Hyg 1993; 87: 186.
15. Da-Cruz AM, Machado ES, Menezes JA et al. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg 1992: 86: 511-12.
16. Cnudde F, Boulard F, Raccurt C et al. Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies. AIDS 1994; 8: 559-60.
17. Gonzalez-Ruperez J, Javaloyas De Morlius M, Moreno Carazo A. Remission of localized cutaneous leishmaniasis in a HIV-positive patient using systemic terbinafine. Dermatology 1997; 194: 85-6.
18. Nogueira-Castanon MCM, Pereira CAC, Furtado T. Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome. Int J Dermatol 1996; 35: 295-7.
19. De Souza e Souza I, Naiff RD, Guimaraes TC et al. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 1998; 10: 214-17.
20. Rosatelli JB, Souza CS, Soare FA et al. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome. J Eur Acad Dermatol Venereol 1998; 10: 229-32.
21. Amato VS, Nicodemo AC, Amato JG et al. Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome). J Antimicrob Chemother 2000; 46: 341-2.
22. Hernandez DE, Oliver M, Martinez C, Planas G. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS). Int J Dermatol 1995; 34: 114-15.
23. Pharoah PDP, Ponnighaus JM, Chavula D, Lucas SB. Two cases of cutaneous leishmaniasis in Malawi. Trans R Soc Trop Med Hyg 1993; 87: 668-70.
24. Berhe N, Hailu A, Gemetchu T. Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica. Trans R Soc Trop Med Hyg 1995; 89: 400-1.
25. Gillis D, Klaus S, Shnur LF et al. Diffusely disseminated cutaneous Leishmania major infection in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1995; 14: 247-9.
26. Ndiaye B, Develoux M, Dieng MT, Huerre M. Leishmaniose cutanée diffuse au cours du syndrome d'immunodéficience acquise chez un patient sénégalais. Bull Soc Pathol Exot 1996; 89: 282-6.
27. Robert-Gangneux F, Baixench MT, Piarroux R et al. Use of molecular tools for the diagnosis and typing of a Leishmania major strain isolated from an HIV-infected patient in Burkina Faso. Trans R Soc Trop Med Hyg 1999; 93: 396-7.
28. Blanche P, Gombert B, Rivoal O et al. Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS. Clin Infect Dis 2002; 34: 1279-80.
29. Grimaldi G Jr, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 1989; 41: 687-725.
30. Pradinaud R, Servans G. La leishmaniose tégumentaire et son traitement par la pentamidine en Guyane Française. Med Hyg 1991; 49: 726-32.
31. Nocito I, Serra E, Montero A. Visceral involvement due to Leishmania mexicana in a patient with acquired immunodeficiency syndrome. Am J Med 2002; 113: 260-2.
32. Dedet JP, Roche B, Pratlong F et al. Diffuse cutaneous infection caused by a presumed monoxenous trypanosomatid in a patient infected with HIV. Trans R Soc Trop Med Hyg 1995: 89: 644-6.
33. Noyes H, Pratlong F, Chance M et al. A previously unclassified trypanosomatid responsible for human cutaneous lesions in Martinique (French West Indies) is the most divergent member of the genus Leishmania ss. Parasitology 2002; 124: 17-24.